Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Glioblastoma 77 Prostatic Neoplasms 56 Carcinoma, Non-Small-Cell Lung 50 Breast Neoplasms 49 Esophageal Neoplasms 47 Rectal Neoplasms 41 Lung Neoplasms 40 Squamous Cell Carcinoma of Head and Neck 32 Gliosarcoma 31 Head and Neck Neoplasms 30 Brain Neoplasms 30 Pancreatic Neoplasms 29 Uterine Cervical Neoplasms 27 Neoplasm Metastasis 23 Glioma 23 Neoplasms 22 Oropharyngeal Neoplasms 20 Esophageal Squamous Cell Carcinoma 20 Sarcoma 19 Melanoma 18 Astrocytoma 17 Adenocarcinoma Of Esophagus 15 Stomach Neoplasms 14 Precursor Cell Lymphoblastic Leukemia-Lymphoma 12 Carcinoma, Squamous Cell 12 Urinary Bladder Neoplasms 11 Lymphoma, Follicular 11 Central Nervous System Neoplasms 11 Carcinoma 11 Burkitt Lymphoma 10

Interventions

Cyclophosphamide 2 toripalimab 1 pembrolizumab 1 fludarabine 1 apatinib 1 TP protocol 1 Surgical Procedures, Operative 1 Radiation 1 Heavy Ion Radiotherapy 1 Drug Therapy 1 Doxorubicin 1 Cisplatin 1 Carboplatin 1 AP 1903 reagent 1 130-nm albumin-bound paclitaxel 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Interventional × Thymic epithelial tumor × Radiation × Clear all

NCT03858582 2021-03-22

neoadjuvant_thymic Epithelial Tumor

Samsung Medical Center

Phase 2 Unknown

Thymic epithelial tumor

Data powered by HemOnc (CC BY 4.0) Colophon ⚡